top of page
Researcher

PROACT EU-Response

Start Date:

January 2025

End Date:

ongoing

Duration:

60 months

ID-CARE Role:
Website:

Partner

Description

GA Number: 101156304


Background:

Recent pandemics showed Europe how serious health threats can be to society. Proactive approaches are needed to ensure that medical countermeasures are available during pandemics. PROACT EU-Response’s overarching objective is to prepare Europe for future pandemics by strengthening upon existing networks of experts and civil society focused

on clinical therapeutic platform trials within hospital inpatient settings across Europe. In case of an outbreak, this network will provide capacity to pivot rapidly to implement large, multi-country platform trials studying therapeutics and diagnostic-tool performance.


Objectives:

Underpinned by strong community involvement and further strengthened by the inclusion of social and implementation scientists, PROACT EU-Response centres on six objectives:

  • expand a solid network of clinical centres across Europe that will implement a clinical trial assessing a syndromic approach for respiratory viral infections;

  • strengthen a laboratory network to identify pathogens and biomarkers of disease monitoring for routine surveillance;

  • support a network of methodologists and trialists who will ensure the trials’ logistical and methodological aspects;

  • initiate a network of professionals to work on preparedness tools to ensure a smooth pivot from inter-pandemic to the pandemic period in case of an outbreak;

  • build a network of social science researchers who will provide nuanced understanding of the social contexts;

  • and establish a community group to work on activities that will empower patients and citizens in Europe regarding their own health and educate them about science and health issues.


By bringing together scientists, social science researchers, and civil society members, PROACT EU-Response will benefit the entire European population and beyond through decreased mortality and morbidity associated with emerging diseases, lower societal economic costs of morbidity, strengthened research and innovation expertise, human capacities, and know-how for combatting communicable diseases.

Partners

Institut national de la santé et de la recherche médicale - FRANCE

Sorbonne Université - FRANCE

Oslo Universitetssykehus HF - NORWAY

Servicio Madrileño de Salud - SPAIN

Fundación para la Investigación Biomédica del Hospital Universitario La Paz - SPAIN

Université Libre de Bruxelles - BELGIUM

Università degli Studi di Verona - ITALY

University College London – UNITED KINGDOM

University College Dublin - IRELAND

European Clinical Research Infrastructure Network - FRANCE

Hospices Civils de Lyon - FRANCE

bioMérieux SA - FRANCE

Assistance Publique - Hôpitaux de Paris - FRANCE

European Patients' Forum - BELGIUM

Collectif No FakeMed - FRANCE

NILE - FRANCE

Les Markabiens - FRANCE

University of Galway - IRELAND

INSERM Transfert SA - FRANCE

Centre National de la Recherche Scientifique - FRANCE

Universiteit Antwerpen - BELGIUM

University of Lancaster – UNITED KINGDOM

University of Bristol – UNITED KINGDOM

Medizinische Universität Wien - AUSTRIA

Stichting Nederlandse Wetenschappelijk Onderzoek Instituten - NETHERLANDS

Universität Basel - SWITZERLAND

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications
ID-CARE Participants

Evelina Tacconelli

Director

Ruth Joanna Davis

Project Officer

In the News
LOGO IDCARE bianco.png
  • Twitter
  • LinkedIn

Borgo Roma-Policlinico G.B. Rossi, Piazzale Antonio Ludovico Scuro, 10, 37134, Verona, Italy.

Borgo Trento-Ospedale Borgo Trento Piazzale Aristide Stefani, 1 - 37126, Verona, Italy

+39 045 8128243

Copyright © 2024 ID-Care.

bottom of page